GRUBER SCOTT L 4
4 · TOMPKINS FINANCIAL CORP · Filed Mar 15, 2021
Insider Transaction Report
Form 4
GRUBER SCOTT L
EVP, Pres. & COO, VIST Bank
Transactions
- Exercise/Conversion
Common Stock
2021-03-12$40.60/sh+459$18,635→ 13,928.182 total - Tax Payment
Common Stock
2021-03-12$92.36/sh−306$28,262→ 13,622.182 total - Tax Payment
Common Stock
2021-03-12$92.36/sh−426$39,345→ 13,786.182 total - Exercise/Conversion
Common Stock
2021-03-12$49.22/sh+590$29,040→ 14,212.182 total - Exercise/Conversion
Common Stock
2021-03-12$56.29/sh+380$21,390→ 14,166.182 total - Tax Payment
Common Stock
2021-03-12$92.36/sh−292$26,969→ 13,874.182 total - Exercise/Conversion
Common Stock
2021-03-12$76.90/sh+201$15,457→ 14,075.182 total - Tax Payment
Common Stock
2021-03-12$92.36/sh−181$16,717→ 13,894.182 total - Exercise/Conversion
Stock Appreciation Rights (SAR)
2021-03-12−459→ 0 totalExercise: $40.60Exp: 2023-05-03→ Common Stock (459 underlying) - Exercise/Conversion
Stock Appreciation Rights (SAR)
2021-03-12−590→ 522 totalExercise: $49.22Exp: 2024-11-21→ Common Stock (590 underlying) - Exercise/Conversion
Stock Appreciation Rights (SAR)
2021-03-12−380→ 716 totalExercise: $56.29Exp: 2025-11-04→ Common Stock (380 underlying) - Exercise/Conversion
Stock Appreciation Rights (SAR)
2021-03-12−201→ 200 totalExercise: $76.90Exp: 2026-11-09→ Common Stock (201 underlying)
Holdings
- 1,014.221(indirect: By 401(k))
Common Stock
- 4,239.834(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Shares withheld for option cost and taxes.
- [F2]Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.
- [F3]Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a five-year vesting schedule, with 0% vesting in year one and 25% vesting in years two through five. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.